PER 13.0% 13.0¢ percheron therapeutics limited

Ann: Funding for ATL1103 Phase II Trial and Pipel, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,102 Posts.
    lightbulb Created with Sketch. 386
    re: Ann: Funding for ATL1103 Phase II Trial a... From memory PRR , hit .40 just by moving into Phase 3.

    ANP has succesfully completed Phase 2, and soon to start Phase 3 and has more in pipeline which is also more advance postion then PRR pipeline.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
13.0¢
Change
0.015(13.0%)
Mkt cap ! $117.2M
Open High Low Value Volume
12.0¢ 13.5¢ 12.0¢ $612.7K 4.843M

Buyers (Bids)

No. Vol. Price($)
2 56662 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 600000 2
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.